16/04/2026
A Positive Shift for MSMEs in Saudi Arabia’s Food & Pharma Sector
The Saudi Food and Drug Authority (SFDA - هيئة الغذاء والدواء) has introduced a significant regulatory update that will directly impact businesses operating in the Kingdom’s food, pharmaceutical, and healthcare sectors.
Under a new framework aligned with Royal Order No. 32043, violations, penalties, and fines will now be classified based on the size of the establishment and its commercial activity. This marks a progressive move toward a more equitable compliance system particularly benefiting Micro, Small, and Medium Enterprises ( ).
📍 Penalties will no longer be “one-size-fits-all”
📍 Fines will be scaled according to business size and activity
📍 Mandatory requirement to obtain a “Certificate of Establishment Size” from MonshaatSA’at (SME General Authority)
Businesses must present this certificate to SFDA when requested
💡 Why This Matters for Indian Businesses
Saudi Arabia is one of India’s most important trade partners in the Gulf, especially in sectors regulated by SFDA:
📌 India exports $1.2–1.5 billion worth of food products annually to Saudi Arabia.
📌 Pharmaceuticals exports from India to KSA exceed $300 million+ annually, making India one of the top suppliers of generic medicines to the Kingdom
📌 Over 2,500+ Indian-owned businesses operate across Saudi Arabia, many in food processing, trading, and healthcare supply chains
For Indian MSMEs and entrepreneurs:
✔️ This reform reduces disproportionate financial risk
✔️ Encourages easier market entry and expansion
✔️ Aligns with Saudi Arabia’s Vision 2030 focus on SME growth
✔️ Promotes a more transparent and predictable regulatory environment
This initiative is a strong signal that Saudi Arabia continues to strengthen its business-friendly ecosystem, creating more inclusive opportunities for international partners—including the vibrant Indian business community.
